Australia's most trusted
source of pharma news
Wednesday, 22 April 2026
Posted 22 April 2026 PM
Johnson & Johnson believes it will hit a record-breaking US$100 billion (AU$139 billion) in revenue this year but not all analysts are so sure.
“We are on track to meet our 2026 target of $100 billion in annual revenue for the first time,” J&J Chairman and CEO Joaquin Duato said during a first-quarter earnings call.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.